DNA image cytometry in bladder cancer: State of the art

Anticancer Research

Volumn 28, Issue 1 B, 2008, Pages 443-450

  Palmeira, Carlos A ^a,b   Oliveira, Paula A ^c,e   Seixas, Fernanda ^c   Pires, Maria A ^c   Lopes, Carlos ^a,d   Santos, Lúcio ^a,b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^c UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Bladder cancer; DNA content; Image cytometry; Review

Indexed keywords

BLADDER CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CYTOMETRY; DNA DETERMINATION; FLOW CYTOMETRY; FOLLOW UP; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

DNA, NEOPLASM; HUMANS; IMAGE CYTOMETRY; URINARY BLADDER NEOPLASMS;

EID: 40549113963     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Wheeless LL, Badalament RA, deVere White RW, Fradet Y and Tribukait B: Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry 14: 478-481, 1993.
2. Goulandris N, Karakitsos P, Georgoulakis J, Bellos C, Deliveliotis C and Legaki S: Deoxyribonucleic acid measurements in transitional cell carcinomas: comparison of flow and image cytometry techniques. J Urol 156: 958-960, 1996.
3. Faranda A, Costa A, Canova S, Abolafio G and Silvestrini R: Image and flow cytometric analyses of DNA content in human solid tumors. A comparative study. Anal Quant Cytol Histol Aug 19: 338-344, 1997.
4. Kumar NU, Dey P, Mondal AK, Singh SK and Vohra H: DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma. Diagn Cytopathol 24: 153-156, 2001.
5. Dalquen P, Kleiber B, Grilli B, Herzog M, Bubendorf L and Oberholzer M: DNA image cytometry and fluorescence in situ hybridization for non-invasive detection of urothelial tumors in voided urine. Cancer (Cancer Cytopathlogy) 96: 374-379, 2002.
6. Baak JPA, Bol MGW, van Diermen B, Janssen EAM, Buhr-Wildhagen SBK, Mestad O, Øgreid P and Kjellevold K-H: DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality. Urology 61: 1266-1272, 2003.
7. Koss LG, Wersto RP, Simmons DA, Deitch D, Herz F and Freed SZ: Predictive value of DNA measuerements in bladder washings. Comparison of flow cytometry, image cytometry, and cytology in patients with a past history of urothelial tumors. Cancer 64: 916-924, 1989.
8. Schapers RF, Ploem-Zaaijer JJ, Pauwels RP, Smeets AW, van den Brandt PA, Tanke HJ and Bosman FT: Image cytometric DNA analysis in transitional cell carcinoma of the bladder. Cancer 72: 182-189, 1993.
9. Clemo FA, Crabtree WN, Walter E and DeNicola DB: Comparison of image analysis and flow cytometric measurements of DNA content of canine transitional cell carcinomas. Anal Quant Cytol Histol 15: 418-426, 1993.
10. Kline MJ, Wilkinson EJ, Askeland R, Given RW, Stephen C and Hendricks JB: DNA tetraploidy in Feulgen-stained bladder washings assessed by image cytometry. Anal Quant Cytol Histol 17: 129-134, 1995.
11. Cajulis RS, Haines GK 3rd, Frias-Hidvegi D, McVary K and Bacus JW: Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study. Diagn Cytopathol 13: 214-223, 1995.
12. Richman AM, Mayne ST, Jekel JF and Albertsen P: Image analysis combined with visual cytology in the early detection of recurrent bladder carcinoma. Cancer 82: 1738-1748, 1998.
13. van der Poel HG, Witjes JA, Schalken JA and Debruyne FMJ: Automated image analysis for bladder cancer. Urol Res 26: 1-5, 1998.
14. Cai T, Margallo E, Nesi G, Giubilei G, Rizzo M and Bartoletti R: Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years' follow-up. Oncol Rep 15: 213-219, 2006.
15. Bol MGW, Baak JPA, Diermen BV, Janssen EAM, Buhr-Wildhagen SBK and Kjellevold K-H: Correlation of grade of urothelial cell carcinomas and DNA histogram features assessed by flow cytometry and automated image cytometry. Anal Cell Pathol 25: 147-153, 2003.
16. Wojcik EM, Brownlie RJ, Bassler TJ and Miller MC: Superficial urothelial (umbrella) cells. A potential cause of abnormal DNA ploidy results in urine specimens. Anal Quant Cytol Histol 22: 411-415, 2000.
17. Forte JD, Croker BP and Hendricks JB: Comparison of histologic and cytologic specimens of urothelial carcinoma with image analysis. Implications for grading. Anal Quant Cytol Histol 19: 158-166, 1997.
18. Mainguene C, Choquenet C, Deplano C, Gavelli A, Clement N, Vanzo E and Hofman P: DNA ploidy by image cytometry in urothelial carcinomas. Comparison of touch imprints and paraffin-embedded biopsies from 31 patients. Anal Quant Cytol Histol 19: 437-442, 1997.
19. Cohen C: Image cytometric analysis in pathology. Hum Pathol 27: 482-493, 1996.
20. Haroske G, Giroud F, Reith A and Böcking A: 1997 ESACP consensus report on diagnostic DNA image cytometry. Anal Cell Pathol 17: 189-200, 1998.
21. Pires MJ, Palmeira C, Rodrigues P, Lopes C and Oliveira-Torres F: Establishment of a diploid reference value for DNA ploidy analysis by image cytometry in mouse cells. Anal Quant Cytol Histol 23: 427-432, 2001.
22. Shabaik AS, Pow-Sang JM, Lockhart J and Nicosis SV: Role of DNA image cytometry in the follow-up of patients with urinary tract transitional cell carcinoma. Anal Quant Cytol Histol 15: 115-123, 1993.
23. Planz B, Synek C, Robben J, Böcking A and Marberger M: Diagnostic accuracy of DNA image cytometry and urinary cytology with cells from voided urine in the detection of bladder cancer. Urology 56: 782-786, 2000.
24. Planz B, Synek C, Deix T, Böcking A and Marberger M: Diagnosis of bladder cancer with urinary cytology, immunocytology and DNA-image - cytometry. Anal Cell Pathol 22: 103-109, 2001.
25. Lokeshwar VB and Soloway MS: Current bladder tumor tests: does their projected utility fulfil clinical necessity? J Urol 165: 1067-1077, 2001.
26. Kouriefs C and Gordon GJ: Diagnostic accuracy of DNA image cytometry and urinary cytology with cells from voided urine in the detection of bladder cancer. Urology 58: 499, 2001.
27. Krause FS, Feil G, Bichler KH, Schrott KM and Akcetin ZY: Clinical aspects for the use of DNA image cytometry in detection of bladder cancer: a valuable tool? DNA Cell Biol 22: 721-725, 2003.
28. Liu J, Katz R, Shin HJC, Johnston DA, Zhang HZ and Caraway NP: Use of mailed urine specimens in diagnosing urothelial carcinoma by cytology and DNA image analysis. Acta Cytol 49: 157-162, 2005.
29. Reeder JE, O'Connell MJ, Yang Z, Morreale JF, Collins L, Frank IN, Messing EM, Cockett AT, Cox C, Robinson RD and Wheeless LL: DNA cytometry and chromosome 9 aberrations by fluorescence in situ hybridization of irrigation specimens from bladder cancer patients. Urology 51: 58-61, 1998.
30. Jiang F, Caraway NP, Sabichi AL, Zhang HZ, Ruitrok A, Grossman HB, Gu J, Lerner SP, Lippman S and Katz RL: Centrosomal abnormality is common in and a potential biomarker for bladder cancer. Int J Cancer 106: 661-665, 2003.
31. Katz RL, Sinkre PA, Zhang HH, Kidd L and Johnston D: Clinical significance of negative and equivocal urinary bladder cytology alone and in combination with DNA image analysis and cystoscopy. Cancer 81: 354-364, 1997.
32. Böcking A, Giroud F and Reith A: Consensus report of the ESACP task force on standardization of diagnostic DNA image cytometry. Anal Cell Pathol 8: 67-74, 1995.
33. Borchers H, Planz B, Jakse G and Böcking A: DNA aneuploidy in G1-urothelial carcinomas of the urinary bladder. Urol Int 52: 145-150, 1994.
34. Planz B, Striepecke E, Wolff JM, Effert P, Jakse G and Böcking A: DNA-aneuploidy as marker for neoplasia in G1-urothelial carcinomas. Gen Diagn Pathol 142: 69-73, 1996.
35. Santos L, Amaro T, Costa C, Pereira S, Bento MJ, Lopes P, Oliveira J, Criado B and Lopes C: Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification. Int J Cancer 105: 267-272, 2003.
36. Hemstreet GP III, Rollins SA Jones P, Rao JY, Hurst RE, Bonner BB, Hewett T and Smith BG: Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue. J Urol 146: 1525-1529, 1991.
37. van Velthoven R, Petein M, Oosterlinck WJ, Roels H, Pasteels JL, Schulman C and Kiss R: The use of digital image analysis of chromatin texture in Feulgen-stained nuclei to predict recurrence of low grade superficial transitional cell carcinoma of the bladder. Cancer 75: 560-568, 1995.
38. van Velthoven R, Petein M, Oosterlinck WJ, Raviv G, Janssen T, Roels H, Pasteels JL, Schulman C and Kiss R: The additional predictive value contributed by quantitative chromatin pattern description as compared to DNA ploidy level measurement in 257 superficial bladder transitional cell carcinomas. Eur Urol 29: 245-251, 1996.
39. Pantazopoulos D, Ioakim-Liossi A, Karakitsos P, Aroni K, Kakoliris S, Kanavaros P and Kyrkou KA: DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder. Anticancer Res 17: 781-786, 1997.
40. Ioakim-Liossi AG, Karakitsos PJ, Pantazopoulos D, Aroni KG and Athanossiadou P: Image cytometric DNA analysis and proliferating cell nuclear antigen (PCNA) expression in transitional cell carcinoma of the bladder. Cancer Detec Prev 23: 401-407, 1999.
41. Ioakim-Liossi A, Pantazopoulos D, Karakitsos P, Athanassiadou P, Aroni K, Chourdakis N, Giachnaki A and Athanassiades P: DNA ploidy and p53 protein expression in superficial transitional cell Carcinoma of the bladder. Cytopathology 11: 96-103, 2000.
42. van Velthoven R, Petein M, Oosterlinck W, De Wilde T, Mattelaer J, Hardeman M, Kiss R and Decaestecker C: Identification by quantitative pattern analysis of patients at risk for recurrence of superficial transitional bladder carcinoma. J Urol 164: 2134-2137, 2000.
43. Onguru O, Celasun B and Gunhan O: Comparison of DNA ploidy and nuclear morphometric parameters with the conventional prognostic factors in transitional cell carcinomas. Tohoku J Exp Med 199: 141-148, 2003.
44. Biesterfeld S, Borchers H, Jellouscheck H, Bono AV, Altwein JE, Algaba F and Jakse G: Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry. Anticancer Res 25: 3243-3249, 2005.
45. van der Poel HG, Witjes JA, van Stratum P, Boon ME, Debruyne FM and Schalken JA: Quanticyt: karyometric analysis of bladder washing for patients with superficial bladder cancer. Urology 48: 357-364, 1996.
46. Shiina H, Igawa M, Nagami H, Yagi H, Urakami S, Yoneda T, Shirakawa H, Ishibe T and Kawanishi M: Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder. Cancer 78: 1762-1774, 1996.
47. Kyroudi-Voulgari A, Kouloukoussa M, Simigiatos C, Karakitsos P, Zervas A, Kittas C and Mitropoulos D: DNA ploidy and immunomarking of bladder urothelial tumors before and after intravesical bacillus Calmette-Guérin treatment. Anal Quant Cytol Histol 27: 52-60, 2005.
48. Decaestecker C, van Velthoven R, Petein M, Janssen T, Salmon I, Pasteels JL, van Ham P, Schulman C and Kiss R: The use of the decision tree technique and image cytometry to characterize aggressiveness in World Health Organization (WHO) grade II superficial transitional cell carcinomas of the bladder. J Pathol 178: 274-283, 1996.
49. Shiina H, Urakami S, Shirakawa H, Shigeno K, Himeno Y, Mizutani M, Igawa M and Ishibe T: Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer. Eur Urol 29: 99-105, 1996.
50. al-Abadi H and Nagel R: Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder. J Urol 151: 37-42, 1994.
51. Oliveira PA, Palmeira C, Lourenço LM and Lopes CA: Evaluation of DNA content in preneoplastic changes of mouse urinary bladder induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. J Exp Clin Cancer Res 24: 609-615, 2005.
52. Oliveira PA, Palmeira CA, Colaço A, De La Cruz LF and Lopes CA: DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Guérin. Anticancer Res 26: 2995-3004, 2006.
53. Oliveira PA, Adega F, Palmeira CA, Chaves RM, Colaço AA, Guedes-Pinto H, De La Cruz LF and Lopes CA: DNA study of bladder papillary tumours chemically induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in Fisher rats. Int J Exp Path 88: 39-46, 2007.
54. Oliveira P, Palmeira C, Colaço A, De la Cruz LF and Lopes C: Cell proliferation and DNA content in rat urothelial lesions after repated intravesical instillations of mitomycin C and bacillus Calmette-Guérin. Urol Int 90: 90-97, 2008.
55. Veltri RW, Partin AW and Miller MC: Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterations. J Cell Biochem Suppl 35: 151-157, 2000.
56. El-kott AF, El-baz MA and Mokhtar AA: Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma. Int Urol Nephrol 3: 237-242, 2006.
57. Leonardi E, Dalla Palma P, Reich A, Caffo O and Luciani L: Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB-1, and an immunohistochemical study. Anal Cell Pathol 21: 21-33, 2000.
58. Bol MGW, Baak JPA, Rep S, Marx WL, Kruse AJ, Bos SP, Kisman O and Voorhorst FJ: Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder. Urology 60: 1124-1130, 2002.
59. Bol MGW, Baak JPA, van Dierman B, Buhr-Wildhagen S, Janssen EAM, Kjellevold KH, Kruse AJ, Mestad O and Øgreid P: Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks. J Clin Pathol 56: 447-452, 2003.
60. Santos L, Lameiras C, Afonso J, Palmeira C, Pereira S, Costa C, Amaro T, Bento MJ, Morais A, Criado B and Lopes C: Is DNA content alteration a consequence of proliferative and differentiation changes in urothelial bladder tumors. Acta Urológica 20: 9-17, 2003.
61. Decaestecker C, Petein M, van Velthoven R, Janssen T, Ravig G, Pasteels JL, Schulman C, van Ham P and Kiss R: The computer-assisted microscope analysis of Feulgen-stained nuclei linked to a supervised learning algorithm as an aid to prognosis assessment in invasive transitional bladder cell carcinoma. Anal Cell Pathol 10: 263-280, 1996.
62. WAF1/CIP1 behave differently in euploid versus aneuploid bladder tumours treated with radiotherapy. Acta Oncologica 40: 644-652, 2001.
63. Yu JM, Zhang H, Wang SQ, Miao HQ, Yang LH, Chen YT and Tian GD: DNA ploidy analysis of effectiveness of radiation therapy for cervical carcinoma. Cancer 68: 76-78, 1991.
64. Jacobsen AB, Pettersen EO, Amellem O, Berner A, Ous S and Fosså SD: The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy. J Urol 147: 34-37, 1992.
65. Hug EB, Donnelly SM, Shipley WU, Heney NM, Kaufman DS, Preffer FI, Schwartz SM, Colvin RB and Althausen AF: Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: a possible predictor for successful bladder preservation following transurethral surgery and chemotherapy-radiotherapy. J Urol 148: 47-51, 1992.
66. Mora LB, Nicosia SV, Pow-Sang JM, Ku NK, Diaz JI, Lockhart J and Einstein A: Ancillary techniques in the followup of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients. J Urol 156: 49-54, 1996.
67. Wiener HG, Remkes GW, Schatzl G, Susani M and Breitenecker G: Quick-staining urinary cytology and bladder wash image analysis with an integrated risk classification: a worthwhile improvement in the follow-up of bladder cancer? Cancer 87: 263-269, 1999.
68. Desgrippes A, Izadifar V, Assailly J, Fontaine E and Beurton D: Diagnosis and prediction of recurrence and progression in superficial bladder cancers with DNA image cytometry and urinary cytology. BJU Int 85: 434-436, 2000.
69. Hemstreet GP III, Yin S, Ma Z, Bonner RB, Bi W, Rao JY, Zang M, Zheng Q, Bane B, Asal N, Li G, Feng P, Hurst RE and Wang W: Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. J Natl Cancer Inst 93: 427-436, 2001.
70. Longatto Filho A, Santinelli A and Montironi R: Cytometric investigations of bladder irrigation/washing and voided urine. Pathologica 93: 164-167, 2001.
71. Caraway NP, Khanna A, Payne L, Kamat AM and Katz RL: Combination of cytologic evaluation and quantitative digital cytometry is reliable in detecting recurrent disease in patients with urinary diversions. Cancer 111: 323-329, 2007.
72. Phillips JL and Richardson IC: Aneuploidy in bladder cancers: utility of fluorescent in situ hybridization in clinical practice. BJU Int 98: 33-37, 2006.
73. Grossman HB, Tangen CM, Cordon-Cardo C, Cote R, Waldman FM, De Vere White RW, Karnad AB, Glode M and Crawford ED: Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: a Southwest Oncology Group Study. Oncol Rep 16: 807-810, 2006.